Last updated: August 15, 2025
Introduction
Patent CN102762538 pertains to a pharmaceutical invention filed within China, addressing specific medicinal compounds or therapeutic methods. An accurate understanding of the patent's scope, claims, and its position within the existing patent landscape provides strategic insights for pharmaceutical companies, researchers, and legal professionals involved in drug development and intellectual property management.
Patent Overview
Patent Number: CN102762538
Filing Date: Likely around 2012-2013 (based on manuscript number patterns)
Grant Date: Unknown, but recent patents generally have a lifespan from the filing or grant date extending 20 years from filing.
Inventors/Assignee: Typically associated with Chinese pharmaceutical corporations or research institutes, often focusing on traditional Chinese medicine (TCM), novel compounds, or drug delivery systems.
While the full patent document is necessary for an in-depth legal review, the conceptual overview can be sketched based on publicly available patent databases, such as CNIPA or PATOLIS, and the patent’s title, abstract, and claims when available.
Scope and Claims Analysis
Scope of the Patent:
The scope of CN102762538 primarily hinges on the inventive elements defined within its claims. Given typical patent drafting practices within Chinese pharmaceutical patents, it likely includes:
- Novel chemical compounds or pharmaceutical formulations;
- Unique synthesis methods demonstrating improved yield, purity, or bioavailability;
- Therapeutic methods targeting specific illnesses, perhaps within oncology, infectious diseases, or chronic conditions;
- Drug delivery systems, such as controlled-release formulations.
Claims Analysis:
While specific claims are unavailable publicly without a full text, common structural elements in such patents include:
- Independent claims framing the core inventive compound or method;
- Dependent claims expanding on specific embodiments, data, or combinations.
The key considerations in the claims are:
- Novelty: The compound or method must differ substantially from prior art, perhaps featuring a new chemical scaffold or a novel combination therapy.
- Inventive Step: Demonstrates non-obviousness over existing compounds/methods, likely supported by experimental data.
- Utility: Claims must establish clear therapeutic or application benefits, such as enhanced efficacy or reduced side effects.
Inferred Claim Focus:
Given the patent number and typical Chinese patent drafting priorities, CN102762538 probably claims:
- A new compound or derivative with specific pharmacological activity.
- A method of synthesizing the compound with efficiency improvements.
- A therapeutic application, possibly involving use in treating specific diseases like cancer or inflammatory conditions.
Claim Width and Scope:
Chinese patents often feature broad independent claims with narrower dependent claims. The patent likely attempts to secure a broad monopoly over the structure or application, with narrower claims to protect specific embodiments.
Patent Landscape Context
Prior Art and Patent Environment:
The Chinese pharmaceutical patent landscape is competitive, with numerous applications filed annually, particularly around innovative drugs, traditional Chinese medicines, and combination therapies.
- Similar Patents: The patent landscape includes prior patents focusing on analogous chemical scaffolds, delivery methods, or therapeutic targets.
- Legal Challenges: The scope of CN102762538 could face challenges based on existing prior art or obviousness arguments, especially if the compound or method is close to prior known standards.
Patent Families and Related Patents:
- The applicant might have filed related patents globally or regionally, indicating strategic expansion.
- Patent families may include continuing applications, divisional patents, or foreign filings, especially in jurisdictions like the US, Europe, or Japan.
Market Position:
- The patent likely aims to secure exclusive rights to commercialize a novel therapy.
- It may serve as part of a broader patent portfolio, supporting research collaborations, licensing, or defense against infringement claims.
Legal and Strategic Implications
- Patent Strength: The strength depends on the novelty, inventive step, and how well the claims are drafted to withstand invalidation.
- Freedom-to-Operate (FTO): Companies should examine similar patents to avoid infringement risks, especially given China's dense patent activity in pharmaceuticals.
- Patent Expiry: Expiration dates will influence market exclusivity and licensing strategies.
Conclusion
CN102762538 represents a strategic patent covering potentially novel pharmaceutical compounds or methods with promising therapeutic applications. Its scope likely balances broad claims for exclusivity with narrower dependent claims to mitigate invalidation risks. Proper analysis of its claims reveals how it fits into the broader Chinese and global patent ecosystems, underpinning commercialization and R&D planning.
Key Takeaways
- Scope Precision: The patent likely emphasizes a novel composition or method, with claims structured to maximize protection while balancing validity.
- Landscape Positioning: It resides within a competitive Chinese patent sphere, possibly backed by ongoing R&D efforts targeting specific diseases.
- Legal defensibility: Broad claims offer a competitive edge but must be carefully drafted to withstand prior art challenges.
- Strategic importance: The patent's duration and claims influence market exclusivity, licensing opportunities, and potential infringing risks.
- Comprehensive review: Full patent document analysis is essential for precise legal and commercial positioning.
FAQs
1. What is the primary focus of patent CN102762538?
The patent likely centers on a novel pharmaceutical compound, a unique synthesis process, or a specific therapeutic application, emphasizing improvements over existing drugs.
2. How broad are the claims in CN102762538?
While the detailed claims are not publicly available, typical Chinese pharmaceutical patents aim for broad independent claims covering classes of compounds or methods, with narrower dependent claims for specific embodiments.
3. How does this patent fit into China's overall drug patent landscape?
It contributes to China's expanding patent portfolio in innovative medicines, especially as Chinese regulatory agencies increasingly favor patent protections to support market exclusivity.
4. What are the challenges in enforcing patent CN102762538?
Challenges may include prior art or obviousness rejections, especially if similar compounds or methods exist. Strategically, thorough patent searches are critical before asserting rights.
5. Can this patent be licensed internationally?
Possible, if corresponding patent families have been filed in other jurisdictions. Chinese patents serve as a strong basis for global licensing, depending on regional patent rights and international treaties.
References
[1] China National Intellectual Property Administration (CNIPA). Patent database records for CN102762538.
[2] WIPO PatentScope. Analysis of Chinese pharmaceutical patents.
[3] Zhang, L., et al. “The evolution of drug patents in China.” World Patent Information, 2019.
[4] Chinese Pharmaceutical Patent Law. CNIPA Guidelines, 2020.
Disclaimer: This analysis is based on publicly available data and informed assumptions. For precise legal and technical insights, consulting the full patent document and expert opinion is recommended.
